Cancer Research UK logo.
SearchDonate
  • Search

A trial of LDE225 with gemcitabine for advanced pancreatic cancer

Overview

Cancer types:

Pancreatic cancer

Status:

Closed

Phase:

Phase 1

Details

This trial is looking at a drug called LDE225 alongside gemcitabine chemotherapy for cancer of the pancreas that has spread.

Recruitment start: 5 March 2012

Recruitment end: 10 October 2013

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Daniel Palmer

Supported by

Novartis

Last reviewed: 23 November 2015

CRUK internal database number: 9326

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.